Cefadroxil

Product NDC: 68180-180
11-digit product format: 681800180
Labeler code: 68180
Product ID: 68180-180_4bedfa21-b374-44cc-9c46-c0e9f330ad37
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Cefadroxil
Dosage form: CAPSULE
Route: ORAL
Labeler: Lupin Pharmaceuticals, Inc.
Application: ANDA065392
Marketing category: ANDA
Marketing start: 2008-04-23
Substance: CEFADROXIL
Active strength: 500 mg/1
Pharmacologic classes: Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A065392-001	CEFADROXIL	CEFADROXIL/CEFADROXIL HEMIHYDRATE	EQ 500MG BASE	CAPSULE / ORAL	AB		2007-05-29

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A065392-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A065392-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2007-05-29	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A065392-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065392-001	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065392-001	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065392-001	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065392-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065392-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065392-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065392-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065392-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065392-001	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065392-001	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065392-001	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065392-001	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065392-001	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065392-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065392-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065392-001	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065392-001	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065392-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065392-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A065392-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A065392-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A065392-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A065392-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A065392-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A065392-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A065392-001	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A065392-001	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A065392-001	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A065392-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A065392-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A065392-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A065392-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A065392-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A065392-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A065392-001	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A065392-001	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A065392-001	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A065392-001	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A065392-001	AB	1	`cb3db0bc1861…`

Additional Listing Data#

Finished product: Yes
Brand name base: Cefadroxil
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
CEFADROXIL	500 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
280111G160	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
309049	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
5fe066ce-2f97-49d7-81bd-a672be1ebecd	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
560bed03-0257-a1db-0638-2c46fc35054c	Product name	2	20170824
34f1b9ee-0673-df8c-ddae-36eaf4c48382	Product name	1	20140508
3793572a-4958-68b2-f923-8cf695ec1cc1	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
68180-180-01	Cefadroxil	100 in 1 BOTTLE	CAPSULE	100		8
68180-180-08	Cefadroxil	50 in 1 BOTTLE	CAPSULE	50		8

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
68180-180-01	EA - Each	68180-180	46352057-1c26-4f9e-95ab-a4bd8f4816b3	1	2012-07-24
68180-180-08	EA - Each	68180-180	3d13d259-6c3d-4761-b54e-e3a9f68360de	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CEFADROXIL	ACTIVE INGREDIENT	280111G160	CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.]	8
CEFADROXIL ANHYDROUS	ACTIVE MOIETY	Q525PA8JJB	CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.]	8
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.]	8
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.]	8
D&C RED NO. 28	INACTIVE INGREDIENT	767IP0Y5NH	CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.]	8
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.]	8
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.]	8
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.]	8
GELATIN	INACTIVE INGREDIENT	2G86QN327L	CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.]	8
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.]	8
POTASSIUM HYDROXIDE	INACTIVE INGREDIENT	WZH3C48M4T	CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.]	8
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.]	8
SHELLAC	INACTIVE INGREDIENT	46N107B71O	CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.]	8
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.]	8
CEFADROXIL	ACTIVE INGREDIENT	280111G160	CEFADROXIL CAPSULE [LUPIN PHARMACEUTICALS, INC.]	4
CEFADROXIL ANHYDROUS	ACTIVE MOIETY	Q525PA8JJB	CEFADROXIL CAPSULE [LUPIN PHARMACEUTICALS, INC.]	4
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CEFADROXIL CAPSULE [LUPIN PHARMACEUTICALS, INC.]	4
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	CEFADROXIL CAPSULE [LUPIN PHARMACEUTICALS, INC.]	4
D&C RED NO. 28	INACTIVE INGREDIENT	767IP0Y5NH	CEFADROXIL CAPSULE [LUPIN PHARMACEUTICALS, INC.]	4
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	CEFADROXIL CAPSULE [LUPIN PHARMACEUTICALS, INC.]	4
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	CEFADROXIL CAPSULE [LUPIN PHARMACEUTICALS, INC.]	4
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	CEFADROXIL CAPSULE [LUPIN PHARMACEUTICALS, INC.]	4
GELATIN	INACTIVE INGREDIENT	2G86QN327L	CEFADROXIL CAPSULE [LUPIN PHARMACEUTICALS, INC.]	4
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CEFADROXIL CAPSULE [LUPIN PHARMACEUTICALS, INC.]	4
POTASSIUM HYDROXIDE	INACTIVE INGREDIENT	WZH3C48M4T	CEFADROXIL CAPSULE [LUPIN PHARMACEUTICALS, INC.]	4
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	CEFADROXIL CAPSULE [LUPIN PHARMACEUTICALS, INC.]	4
SHELLAC	INACTIVE INGREDIENT	46N107B71O	CEFADROXIL CAPSULE [LUPIN PHARMACEUTICALS, INC.]	4
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CEFADROXIL CAPSULE [LUPIN PHARMACEUTICALS, INC.]	4
CEFADROXIL	ACTIVE INGREDIENT	280111G160	CEFADROXIL CAPSULE [H.J. HARKINS COMPANY, INC.]	2
CEFADROXIL	ACTIVE INGREDIENT	280111G160	CEFADROXIL CAPSULE [BLENHEIM PHARMACAL, INC.]	2
CEFADROXIL ANHYDROUS	ACTIVE MOIETY	Q525PA8JJB	CEFADROXIL CAPSULE [H.J. HARKINS COMPANY, INC.]	2
CEFADROXIL ANHYDROUS	ACTIVE MOIETY	Q525PA8JJB	CEFADROXIL CAPSULE [BLENHEIM PHARMACAL, INC.]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CEFADROXIL CAPSULE [H.J. HARKINS COMPANY, INC.]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CEFADROXIL CAPSULE [BLENHEIM PHARMACAL, INC.]	2
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	CEFADROXIL CAPSULE [BLENHEIM PHARMACAL, INC.]	2
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	CEFADROXIL CAPSULE [H.J. HARKINS COMPANY, INC.]	2
D&C RED NO. 28	INACTIVE INGREDIENT	767IP0Y5NH	CEFADROXIL CAPSULE [BLENHEIM PHARMACAL, INC.]	2
D&C RED NO. 28	INACTIVE INGREDIENT	767IP0Y5NH	CEFADROXIL CAPSULE [H.J. HARKINS COMPANY, INC.]	2
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	CEFADROXIL CAPSULE [BLENHEIM PHARMACAL, INC.]	2
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	CEFADROXIL CAPSULE [H.J. HARKINS COMPANY, INC.]	2
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	CEFADROXIL CAPSULE [H.J. HARKINS COMPANY, INC.]	2
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	CEFADROXIL CAPSULE [BLENHEIM PHARMACAL, INC.]	2
FERRIC OXIDE BLACK	INACTIVE INGREDIENT	XM0M87F357	CEFADROXIL CAPSULE [H.J. HARKINS COMPANY, INC.]	2
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	CEFADROXIL CAPSULE [BLENHEIM PHARMACAL, INC.]	2
GELATIN	INACTIVE INGREDIENT	2G86QN327L	CEFADROXIL CAPSULE [BLENHEIM PHARMACAL, INC.]	2
GELATIN	INACTIVE INGREDIENT	2G86QN327L	CEFADROXIL CAPSULE [H.J. HARKINS COMPANY, INC.]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CEFADROXIL CAPSULE [BLENHEIM PHARMACAL, INC.]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CEFADROXIL CAPSULE [H.J. HARKINS COMPANY, INC.]	2
POTASSIUM HYDROXIDE	INACTIVE INGREDIENT	WZH3C48M4T	CEFADROXIL CAPSULE [BLENHEIM PHARMACAL, INC.]	2
POTASSIUM HYDROXIDE	INACTIVE INGREDIENT	WZH3C48M4T	CEFADROXIL CAPSULE [H.J. HARKINS COMPANY, INC.]	2
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	CEFADROXIL CAPSULE [H.J. HARKINS COMPANY, INC.]	2
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	CEFADROXIL CAPSULE [BLENHEIM PHARMACAL, INC.]	2
SHELLAC	INACTIVE INGREDIENT	46N107B71O	CEFADROXIL CAPSULE [BLENHEIM PHARMACAL, INC.]	2
SHELLAC	INACTIVE INGREDIENT	46N107B71O	CEFADROXIL CAPSULE [H.J. HARKINS COMPANY, INC.]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CEFADROXIL CAPSULE [BLENHEIM PHARMACAL, INC.]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CEFADROXIL CAPSULE [H.J. HARKINS COMPANY, INC.]	2
CEFADROXIL	ACTIVE INGREDIENT	280111G160	CEFADROXIL CAPSULE [AIDAREX PHARMACEUTICALS LLC]	1
CEFADROXIL	ACTIVE INGREDIENT	280111G160	CEFADROXIL CAPSULE [REBEL DISTRIBUTORS CORP]	1
CEFADROXIL	ACTIVE INGREDIENT	280111G160	CEFADROXIL CAPSULE [PREFERRED PHARMACEUTICALS, INC.]	1
CEFADROXIL ANHYDROUS	ACTIVE MOIETY	Q525PA8JJB	CEFADROXIL CAPSULE [AIDAREX PHARMACEUTICALS LLC]	1
CEFADROXIL ANHYDROUS	ACTIVE MOIETY	Q525PA8JJB	CEFADROXIL CAPSULE [PREFERRED PHARMACEUTICALS, INC.]	1
CEFADROXIL ANHYDROUS	ACTIVE MOIETY	Q525PA8JJB	CEFADROXIL CAPSULE [REBEL DISTRIBUTORS CORP]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CEFADROXIL CAPSULE [PREFERRED PHARMACEUTICALS, INC.]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CEFADROXIL CAPSULE [AIDAREX PHARMACEUTICALS LLC]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CEFADROXIL CAPSULE [REBEL DISTRIBUTORS CORP]	1
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	CEFADROXIL CAPSULE [AIDAREX PHARMACEUTICALS LLC]	1
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	CEFADROXIL CAPSULE [REBEL DISTRIBUTORS CORP]	1
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	CEFADROXIL CAPSULE [PREFERRED PHARMACEUTICALS, INC.]	1
D&C RED NO. 28	INACTIVE INGREDIENT	767IP0Y5NH	CEFADROXIL CAPSULE [REBEL DISTRIBUTORS CORP]	1
D&C RED NO. 28	INACTIVE INGREDIENT	767IP0Y5NH	CEFADROXIL CAPSULE [AIDAREX PHARMACEUTICALS LLC]	1
D&C RED NO. 28	INACTIVE INGREDIENT	767IP0Y5NH	CEFADROXIL CAPSULE [PREFERRED PHARMACEUTICALS, INC.]	1
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	CEFADROXIL CAPSULE [AIDAREX PHARMACEUTICALS LLC]	1
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	CEFADROXIL CAPSULE [PREFERRED PHARMACEUTICALS, INC.]	1
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	CEFADROXIL CAPSULE [REBEL DISTRIBUTORS CORP]	1
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	CEFADROXIL CAPSULE [REBEL DISTRIBUTORS CORP]	1
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	CEFADROXIL CAPSULE [AIDAREX PHARMACEUTICALS LLC]	1
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	CEFADROXIL CAPSULE [PREFERRED PHARMACEUTICALS, INC.]	1
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	CEFADROXIL CAPSULE [PREFERRED PHARMACEUTICALS, INC.]	1
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	CEFADROXIL CAPSULE [AIDAREX PHARMACEUTICALS LLC]	1
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	CEFADROXIL CAPSULE [REBEL DISTRIBUTORS CORP]	1
GELATIN	INACTIVE INGREDIENT	2G86QN327L	CEFADROXIL CAPSULE [AIDAREX PHARMACEUTICALS LLC]	1
GELATIN	INACTIVE INGREDIENT	2G86QN327L	CEFADROXIL CAPSULE [PREFERRED PHARMACEUTICALS, INC.]	1
GELATIN	INACTIVE INGREDIENT	2G86QN327L	CEFADROXIL CAPSULE [REBEL DISTRIBUTORS CORP]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CEFADROXIL CAPSULE [AIDAREX PHARMACEUTICALS LLC]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CEFADROXIL CAPSULE [REBEL DISTRIBUTORS CORP]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CEFADROXIL CAPSULE [PREFERRED PHARMACEUTICALS, INC.]	1
POTASSIUM HYDROXIDE	INACTIVE INGREDIENT	WZH3C48M4T	CEFADROXIL CAPSULE [AIDAREX PHARMACEUTICALS LLC]	1
POTASSIUM HYDROXIDE	INACTIVE INGREDIENT	WZH3C48M4T	CEFADROXIL CAPSULE [PREFERRED PHARMACEUTICALS, INC.]	1
POTASSIUM HYDROXIDE	INACTIVE INGREDIENT	WZH3C48M4T	CEFADROXIL CAPSULE [REBEL DISTRIBUTORS CORP]	1
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	CEFADROXIL CAPSULE [PREFERRED PHARMACEUTICALS, INC.]	1
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	CEFADROXIL CAPSULE [REBEL DISTRIBUTORS CORP]	1
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	CEFADROXIL CAPSULE [AIDAREX PHARMACEUTICALS LLC]	1
SHELLAC	INACTIVE INGREDIENT	46N107B71O	CEFADROXIL CAPSULE [REBEL DISTRIBUTORS CORP]	1
SHELLAC	INACTIVE INGREDIENT	46N107B71O	CEFADROXIL CAPSULE [PREFERRED PHARMACEUTICALS, INC.]	1
SHELLAC	INACTIVE INGREDIENT	46N107B71O	CEFADROXIL CAPSULE [AIDAREX PHARMACEUTICALS LLC]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CEFADROXIL CAPSULE [AIDAREX PHARMACEUTICALS LLC]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CEFADROXIL CAPSULE [PREFERRED PHARMACEUTICALS, INC.]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CEFADROXIL CAPSULE [REBEL DISTRIBUTORS CORP]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68180-180	CEFADROXIL CAPSULE [LUPIN PHARMACEUTICALS, INC.]	7	Current NDC, Legacy NDC, 2 package rows	20250130_5fe066ce-2f97-49d7-81bd-a672be1ebecd.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 10 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Cefadroxil	CEFADROXIL	Proficient Rx LP	57eebea5-28b6-44a3-888b-76950f6038f4	2026-06-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065392 application number: ANDA065392
Cefadroxil	CEFADROXIL	REMEDYREPACK INC.	eb365f05-1c8f-4495-b443-abb0580b39fb	2026-04-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065392 application number: ANDA065392
Cefadroxil	CEFADROXIL	Preferred Pharmaceuticals, Inc.	485bc35b-637a-426b-aaa2-023c664914ae	2026-03-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065392 application number: ANDA065392
Cefadroxil	CEFADROXIL	Redpharm Drug	1c50c0db-ca03-6217-e063-6294a90a89fa	2025-12-25	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065392 application number: ANDA065392
Cefadroxil	CEFADROXIL	NuCare Pharmaceuticals,Inc.	7e931c7e-5ab6-c39c-e053-2a91aa0a59d9	2025-11-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065392 application number: ANDA065392
Cefadroxil	CEFADROXIL	Lupin Pharmaceuticals, Inc.	5fe066ce-2f97-49d7-81bd-a672be1ebecd	2025-10-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065392 application number: ANDA065392 ndc (product): 68180-180
Cefadroxil	CEFADROXIL	Bryant Ranch Prepack	caee9515-9a10-4020-af47-e9833aa69ef8	2025-06-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065392 application number: ANDA065392
Cefadroxil	CEFADROXIL	PD-Rx Pharmaceuticals, Inc.	f5bbbf87-f059-4bbd-aea9-27d31462654f	2025-02-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065392 application number: ANDA065392
Cefadroxil	CEFADROXIL	Direct_Rx	f6ddd84a-4a44-7035-e053-6294a90a6606	2025-01-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065392 application number: ANDA065392
Cefadroxil	CEFADROXIL	Advanced Rx of Tennessee, LLC	205cb17b-6fbf-e147-e063-6294a90a608e	2024-08-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065392 application number: ANDA065392

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
280111G160	CEFADROXIL	66592-87-8	CEFADROXIL

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
309049	cefadroxil 500 MG Oral Capsule	PSN	f5bbbf87-f059-4bbd-aea9-27d31462654f	20
309049	cefadroxil 500 MG Oral Capsule	SCD	f5bbbf87-f059-4bbd-aea9-27d31462654f	20
309049	cefadroxil (as cefadroxil monohydrate) 500 MG Oral Capsule	SY	f5bbbf87-f059-4bbd-aea9-27d31462654f	20
309049	cefadroxil 500 MG Oral Capsule	PSN	5fe066ce-2f97-49d7-81bd-a672be1ebecd	8
309049	cefadroxil 500 MG Oral Capsule	SCD	5fe066ce-2f97-49d7-81bd-a672be1ebecd	8
309049	cefadroxil (as cefadroxil monohydrate) 500 MG Oral Capsule	SY	5fe066ce-2f97-49d7-81bd-a672be1ebecd	8
309049	cefadroxil 500 MG Oral Capsule	PSN	7e931c7e-5ab6-c39c-e053-2a91aa0a59d9	5
309049	cefadroxil 500 MG Oral Capsule	PSN	eb365f05-1c8f-4495-b443-abb0580b39fb	5
309049	cefadroxil 500 MG Oral Capsule	PSN	eddf5ff1-4e3b-40e7-b037-df034f57f9f6	5
309049	cefadroxil 500 MG Oral Capsule	PSN	57eebea5-28b6-44a3-888b-76950f6038f4	5
309049	cefadroxil 500 MG Oral Capsule	SCD	7e931c7e-5ab6-c39c-e053-2a91aa0a59d9	5
309049	cefadroxil 500 MG Oral Capsule	SCD	eb365f05-1c8f-4495-b443-abb0580b39fb	5
309049	cefadroxil 500 MG Oral Capsule	SCD	eddf5ff1-4e3b-40e7-b037-df034f57f9f6	5
309049	cefadroxil 500 MG Oral Capsule	SCD	57eebea5-28b6-44a3-888b-76950f6038f4	5
309049	cefadroxil (as cefadroxil monohydrate) 500 MG Oral Capsule	SY	7e931c7e-5ab6-c39c-e053-2a91aa0a59d9	5
309049	cefadroxil (as cefadroxil monohydrate) 500 MG Oral Capsule	SY	eb365f05-1c8f-4495-b443-abb0580b39fb	5
309049	cefadroxil (as cefadroxil monohydrate) 500 MG Oral Capsule	SY	57eebea5-28b6-44a3-888b-76950f6038f4	5
309049	cefadroxil (as cefadroxil monohydrate) 500 MG Oral Capsule	SY	eddf5ff1-4e3b-40e7-b037-df034f57f9f6	5
309049	cefadroxil 500 MG Oral Capsule	PSN	485bc35b-637a-426b-aaa2-023c664914ae	4
309049	cefadroxil 500 MG Oral Capsule	PSN	3d958dea-aed7-1ef7-e054-00144ff8d46c	4
309049	cefadroxil 500 MG Oral Capsule	PSN	691e3784-84bf-4e7f-e053-2991aa0a5a24	4
309049	cefadroxil 500 MG Oral Capsule	PSN	f6ddd84a-4a44-7035-e053-6294a90a6606	4
309049	cefadroxil 500 MG Oral Capsule	SCD	485bc35b-637a-426b-aaa2-023c664914ae	4
309049	cefadroxil 500 MG Oral Capsule	SCD	3d958dea-aed7-1ef7-e054-00144ff8d46c	4
309049	cefadroxil 500 MG Oral Capsule	SCD	691e3784-84bf-4e7f-e053-2991aa0a5a24	4
309049	cefadroxil 500 MG Oral Capsule	SCD	f6ddd84a-4a44-7035-e053-6294a90a6606	4
309049	cefadroxil (as cefadroxil monohydrate) 500 MG Oral Capsule	SY	485bc35b-637a-426b-aaa2-023c664914ae	4
309049	cefadroxil (as cefadroxil monohydrate) 500 MG Oral Capsule	SY	3d958dea-aed7-1ef7-e054-00144ff8d46c	4
309049	cefadroxil (as cefadroxil monohydrate) 500 MG Oral Capsule	SY	691e3784-84bf-4e7f-e053-2991aa0a5a24	4
309049	cefadroxil (as cefadroxil monohydrate) 500 MG Oral Capsule	SY	f6ddd84a-4a44-7035-e053-6294a90a6606	4
309049	cefadroxil 500 MG Oral Capsule	PSN	7d49a2f4-c2b9-4127-82df-092da20a35d0	2
309049	cefadroxil 500 MG Oral Capsule	PSN	1c50c0db-ca03-6217-e063-6294a90a89fa	2
309049	cefadroxil 500 MG Oral Capsule	PSN	615617a6-40b9-46e2-9a3d-169ea5a671de	2
309049	cefadroxil 500 MG Oral Capsule	SCD	615617a6-40b9-46e2-9a3d-169ea5a671de	2
309049	cefadroxil 500 MG Oral Capsule	SCD	7d49a2f4-c2b9-4127-82df-092da20a35d0	2
309049	cefadroxil 500 MG Oral Capsule	SCD	1c50c0db-ca03-6217-e063-6294a90a89fa	2
309049	cefadroxil (as cefadroxil monohydrate) 500 MG Oral Capsule	SY	1c50c0db-ca03-6217-e063-6294a90a89fa	2
309049	cefadroxil (as cefadroxil monohydrate) 500 MG Oral Capsule	SY	615617a6-40b9-46e2-9a3d-169ea5a671de	2
309049	cefadroxil (as cefadroxil monohydrate) 500 MG Oral Capsule	SY	7d49a2f4-c2b9-4127-82df-092da20a35d0	2
309049	cefadroxil 500 MG Oral Capsule	PSN	d433e4e8-9f38-405e-ac80-bc8dfcba0649	1
309049	cefadroxil 500 MG Oral Capsule	PSN	caee9515-9a10-4020-af47-e9833aa69ef8	1
309049	cefadroxil 500 MG Oral Capsule	PSN	42f92a36-4c11-44f6-8f82-716a8b7a3f08	1
309049	cefadroxil 500 MG Oral Capsule	PSN	205cb17b-6fbf-e147-e063-6294a90a608e	1
309049	cefadroxil 500 MG Oral Capsule	PSN	7df07f19-1eb2-6894-e053-2991aa0a8d41	1
309049	cefadroxil 500 MG Oral Capsule	SCD	caee9515-9a10-4020-af47-e9833aa69ef8	1
309049	cefadroxil 500 MG Oral Capsule	SCD	d433e4e8-9f38-405e-ac80-bc8dfcba0649	1
309049	cefadroxil 500 MG Oral Capsule	SCD	7df07f19-1eb2-6894-e053-2991aa0a8d41	1
309049	cefadroxil 500 MG Oral Capsule	SCD	42f92a36-4c11-44f6-8f82-716a8b7a3f08	1
309049	cefadroxil 500 MG Oral Capsule	SCD	205cb17b-6fbf-e147-e063-6294a90a608e	1
309049	cefadroxil (as cefadroxil monohydrate) 500 MG Oral Capsule	SY	d433e4e8-9f38-405e-ac80-bc8dfcba0649	1
309049	cefadroxil (as cefadroxil monohydrate) 500 MG Oral Capsule	SY	caee9515-9a10-4020-af47-e9833aa69ef8	1
309049	cefadroxil (as cefadroxil monohydrate) 500 MG Oral Capsule	SY	42f92a36-4c11-44f6-8f82-716a8b7a3f08	1
309049	cefadroxil (as cefadroxil monohydrate) 500 MG Oral Capsule	SY	205cb17b-6fbf-e147-e063-6294a90a608e	1
309049	cefadroxil (as cefadroxil monohydrate) 500 MG Oral Capsule	SY	7df07f19-1eb2-6894-e053-2991aa0a8d41	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
68180-180-01	68180018001	100 CAPSULE in 1 BOTTLE (68180-180-01)	100 capsule	2008-04-23	0000-00-00	No	No	Current
68180-180-08	68180018008	50 CAPSULE in 1 BOTTLE (68180-180-08)	50 capsule	2008-04-23	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Cefadroxil Capsules USP 500 mg	Proficient Rx LP	2026-06-01	HUMAN PRESCRIPTION DRUG LABEL	6
Cefadroxil Capsules USP 500 mg	REMEDYREPACK INC.	2026-04-13	HUMAN PRESCRIPTION DRUG LABEL	5
Cefadroxil Capsules USP 500 mg	Preferred Pharmaceuticals, Inc.	2026-03-24	HUMAN PRESCRIPTION DRUG LABEL	4
Cefadroxil Capsules USP 500 mg	Redpharm Drug	2025-12-25	HUMAN PRESCRIPTION DRUG LABEL	2
Cefadroxil Capsules USP 500 mg	NuCare Pharmaceuticals,Inc.	2025-11-19	HUMAN PRESCRIPTION DRUG LABEL	5
Cefadroxil Capsules USP 500 mg	Lupin Pharmaceuticals, Inc.	2025-10-10	HUMAN PRESCRIPTION DRUG LABEL	8
Cefadroxil Capsules USP 500 mg	Bryant Ranch Prepack	2025-06-20	HUMAN PRESCRIPTION DRUG LABEL	1
Cefadroxil Capsules USP 500 mg	PD-Rx Pharmaceuticals, Inc.	2025-02-28	HUMAN PRESCRIPTION DRUG LABEL	20
Cefadroxil	Direct_Rx	2025-01-22	HUMAN PRESCRIPTION DRUG LABEL	4
Cefadroxil Capsules USP	Advanced Rx of Tennessee, LLC	2024-08-23	HUMAN PRESCRIPTION DRUG LABEL	1
Cefadroxil Capsules USP 500 mg	A-S Medication Solutions	2024-05-20	HUMAN PRESCRIPTION DRUG LABEL	16
Cefadroxil Capsules USP 500 mg	RPK Pharmaceuticals, Inc.	2023-06-07	HUMAN PRESCRIPTION DRUG LABEL	5
Cefadroxil Capsules USP 500 mg	NuCare Pharmaceuticals, Inc.	2023-03-10	HUMAN PRESCRIPTION DRUG LABEL	4
Cefadroxil Capsules USP 500 mg	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	2020-11-30	HUMAN PRESCRIPTION DRUG LABEL	4
Cefadroxil Capsules USP 500 mg	Bryant Ranch Prepack	2019-08-17	HUMAN PRESCRIPTION DRUG LABEL	3
Cefadroxil Capsules USP 500 mg	Preferred Pharmaceuticals, Inc.	2019-07-11	HUMAN PRESCRIPTION DRUG LABEL	4
Cefadroxil Capsules USP 500 mg	medsource pharmaceutocals \| medsource pharmaceuticals	2018-12-26	HUMAN PRESCRIPTION DRUG LABEL	1
Cefadroxil Capsules USP 500 mg	Blenheim Pharmacal, Inc.	2015-11-10	HUMAN PRESCRIPTION DRUG LABEL	2
Cefadroxil Capsules USP 500 mg	Aidarex Pharmaceuticals LLC	2013-12-16	HUMAN PRESCRIPTION DRUG LABEL	1
Cefadroxil Capsules USP 500 mg	Rebel Distributors Corp	2012-03-13	HUMAN PRESCRIPTION DRUG LABEL	1
Cefadroxil Capsules USP 500 mg	H.J. Harkins Company, Inc.	2012-01-19	HUMAN PRESCRIPTION DRUG LABEL	2